Free tool
Cell therapy stocks
We cover 5 companies grouped under the Cell therapy theme. The median market value in the group is $355.75M. Across the group, the median move over the past trading day is +0.54%. Price change over the past year runs from −25.9% to +170.5% across the middle 80 percent of the group, with a median of +17.0%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 86 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| SYNC.L | Syncona Limited | $933.97M | Small cap | +17.03% | Nov 12, 2026 |
| 0JDK.L | Iovance Biotherapeutics, Inc. | $501.00M | Small cap | +265.60% | Nov 5, 2026 |
| ALCLS.PA | Cellectis S.A. | $355.75M | Small cap | +27.74% | Nov 13, 2026 |
| 0HIY.L | Atara Biotherapeutics, Inc. | $124.82M | Small cap | −23.28% | Nov 12, 2026 |
| PSH0.DE | Sernova Biotherapeutics Inc | $30.82M | Micro cap | −27.68% | Sep 10, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.